Cargando…

A sepsis progression model in humans: characterization of biomarkers descriptive of sepsis progression

Detalles Bibliográficos
Autores principales:	Footer, BW, Hsiao, C-B, Parish, DM, Wickremasingha, P, Halim, A-B, Senaldi, G, Scheyer, R, Schentag, JJ
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3239280/ http://dx.doi.org/10.1186/cc10406

Ejemplares similares

Estimating coagulopathy in an ovine acute lung injury model of sepsis using a disease progression model
por: Footer, BW, et al.
Publicado: (2010)

Modeling sepsis induced by methicillin-resistant Staphylococcus aureus infection: a human/ovine approach
por: Schentag, JJ, et al.
Publicado: (2010)

Predicting organ failure at 24 hours from early clinical data in an ovine pneumonia-sepsis model
por: Footer, BW, et al.
Publicado: (2010)

Modeling sepsis using neural nets and biomarkers of organ dysfunction in patients, with links to animal models
por: Schentag, J, et al.
Publicado: (2012)

Hemostasis system condition in progress of sepsis in severe burns
por: Presnyakova, M, et al.
Publicado: (2011)

Sphingosine-1 phosphate promotes thymic atrophy during sepsis progression
por: Kuchler, L, et al.
Publicado: (2014)

Biomarkers of sepsis in burn patients
por: Oueslati, H, et al.
Publicado: (2010)

Microalbuminuria: a biomarker of sepsis
por: Basu, S, et al.
Publicado: (2009)

Lactate in burn patients: biomarker of sepsis and mortality
por: Mokline, A, et al.
Publicado: (2012)

Use of a screening authorization and randomization center for severe sepsis patient qualification and real-time enrollment in a phase 2 trial of eritoran tetrasodium (E5564), a TLR4 antagonist
por: Schentag, J, et al.
Publicado: (2009)

Atorvastatin for preventing the progression of sepsis to severe sepsis (ASEPSIS Trial): a randomised, double-blind, placebo-controlled trial (ISRCTN64637517)
por: Patel, JM, et al.
Publicado: (2011)

Pro-adrenomedullin as prognostic biomarker in the sepsis
por: De La Torre-Prados, M, et al.
Publicado: (2013)

Biomarkers in sepsis: a systematic review
por: Morriello, F, et al.
Publicado: (2015)

Severe sepsis and drotrecogin alfa (activated) use: results from the PROGRESS registry
por: Beale, R, et al.
Publicado: (2007)

The importance of antibiotics in animal models of sepsis
por: Maybauer, MO, et al.
Publicado: (2005)

A novel molecular biomarker diagnostic for the early detection of sepsis
por: Venter, D, et al.
Publicado: (2010)

Assessment of clinical deterioration and progressive organ failure in moderate-severity emergency department sepsis patients
por: Arnold, R, et al.
Publicado: (2012)

Prognosis value of biomarkers in severe sepsis and septic shock
por: De La Torre-Prados, MV, et al.
Publicado: (2015)

Pro-atrial natriuretic peptide in patients with sepsis, severe sepsis and septic shock
por: Prucha, M, et al.
Publicado: (2005)

Time course of IL-6 and LBP, candidate biomarkers of sepsis in surgical critical care
por: Kipnis, E, et al.
Publicado: (2010)

An epidemiological study of sepsis in ICUs: Sepsis Brazil Study
por: Sales, J, et al.
Publicado: (2006)

Severe sepsis: international and specialty variations in initial management
por: Reade, MC, et al.
Publicado: (2008)

Procalcitonin as a prognostic biomarker of severe sepsis and septic shock
por: de Azevedo, JRA, et al.
Publicado: (2013)

Sphingosine-1-phosphate is a novel biomarker in sepsis severity
por: Nierhaus, A, et al.
Publicado: (2015)

21. Sepsis?
por: Zacharias, Hannah, et al.
Publicado: (2019)

Sepsis and neutropenia in hematological malignancies
por: Labiad, Y, et al.
Publicado: (2014)

Impact of the Surviving Sepsis Campaign implementation on severe sepsis outcome
por: Silva, E
Publicado: (2011)

Costs of severe sepsis according to the guidelines of the 'Surviving Sepsis Campaign'
por: de Anda, G Vazquez, et al.
Publicado: (2005)

Early recognition of sepsis: an audit of sepsis diagnosis and initial management
por: Simon, JB, et al.
Publicado: (2015)

Experimental wound healing in severe sepsis and septic shock in humans
por: Koskela, M, et al.
Publicado: (2008)

Impaired heart rate variability predicts clinical deterioration and progressive organ failure in emergency department sepsis patients
por: Arnold, R, et al.
Publicado: (2012)

Evaluation of the cost of severe sepsis and septic shock in a private ICU in Brazil
por: Velasco, M Borges, et al.
Publicado: (2015)

Sublingual leukocyte activation in patients with severe sepsis or septic shock
por: Fabian-Jessing, BK, et al.
Publicado: (2015)

Impact of an educational program on the Surviving Sepsis Campaign implementation for sepsis management
por: d'Empaire, Pablo Perez, et al.
Publicado: (2008)

ICU mortality rates in patients with sepsis compared with patients without sepsis
por: Melville, J, et al.
Publicado: (2015)

Test characteristics of acute kidney injury biomarkers in animal models of sepsis
por: Peng, Z, et al.
Publicado: (2014)

Sphingosine-1-phosphate is a new biomarker for severity in human sepsis
por: Winkler, MS, et al.
Publicado: (2015)

Role of nurses in the early recognition of sepsis
por: Padilha, P, et al.
Publicado: (2011)

Time to antibiotics in sepsis
por: Appelboam, R, et al.
Publicado: (2010)

Improved detection of sepsis
por: Nielsen, Jane Bach, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_02ib4odmo32hnvl3mbvjouuk3r